Psychedelic Stocks With Oregon Legalizing Psilocybin Therapy, Will The Federal Government Finally Move TO Decriminalize Psychedelics? By Larry Zweig March 30, 2021 Although psychedelic reform is not a top priority for President Joe Biden's administration, advocates are optimistic that with the new administration, there might some new policy changes that will decriminalize MDMA, psilocybin, a...
Psychedelic Stocks Mindset Pharma Files For A Provisional Patent For A New Psychedelic-based Pipeline Drug By Larry Zweig January 05, 2021 Mindset Pharma is on the fast track in the race for psychedelics-based medicines and it is rapidly expanding its portfolio. It is one of the companies that are aggressively pushing into the new frontier of medical research involvi...
Psychedelic Stocks UK Regulators Explore DMT As A Potential Anti-Depression Therapy By Larry Zweig December 19, 2020 UK researchers are planning to conduct a clinical study that will give them insights into dimethyltryptamine’s (DMT) mechanisms that provide therapeutic advantages against mental health illnesses. The research will be backed by...
Psychedelic Stocks Health Canada Allows Some Healthcare Professionals To Use Psilocybin By Larry Zweig December 15, 2020 Health Canada has cleared some healthcare professionals that include doctors and therapists to start using psilocybin mushrooms in treating patients allowed to use psychedelic drugs. The approval comes four months after Health Can...
Psychedelic Stocks New Research Shows That Psychedelic 5-Methocy-N,-N-Dimethyltryptamine Can Improve Anxiety And Depression By Larry Zweig December 02, 2020 A recent John Hopkins study has established that the use of synthetic psychedelic 5-methocy-N,-N-dimethyltryptamine (5-MeO-DMT) is related to unintentional improvement in self-reported anxiety and depression. 5-MeO-DMT is a psyche...
